{"result": {"id": "03ac91f2-143e-451d-a319-7cbc7299e1f4", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>多巴胺<|>ORGANIZATION<|>多巴胺 is a neurotransmitter and its metabolites are measured in PPGL diagnosis\")  \n##\n(\"entity\"<|>高香草酸<|>ORGANIZATION<|>高香草酸 is a terminal metabolite of dopamine used in biochemical testing\")  \n##\n(\"entity\"<|>香草扁桃酸<|>ORGANIZATION<|>香草扁桃酸 is a catecholamine metabolite analyzed for PPGL diagnosis\")  \n##\n(\"entity\"<|>儿茶酚胺<|>ORGANIZATION<|>儿茶酚胺 levels are critical for PPGL biochemical evaluation and follow-up\")  \n##\n(\"entity\"<|>甲氧基肾上腺素<|>ORGANIZATION<|>甲氧基肾上腺素 is a biomarker monitored in PPGL post-treatment surveillance\")  \n##\n(\"entity\"<|>甲氧基去甲肾上腺素<|>ORGANIZATION<|>甲氧基去甲肾上腺素 is a metabolite tracked during PPGL patient follow-up\")  \n##\n(\"entity\"<|>α受体阻滞剂<|>ORGANIZATION<|>α受体阻滞剂 are drugs used for preoperative preparation in most PPGL cases\")  \n##\n(\"entity\"<|>β受体阻滞剂<|>ORGANIZATION<|>β受体阻滞剂 are adjunctive medications for tachycardia during PPGL preoperative preparation\")  \n##\n(\"relationship\"<|>多巴胺<|>高香草酸<|>高香草酸 is a terminal metabolite of dopamine<|>8)  \n##\n(\"relationship\"<|>多巴胺<|>香草扁桃酸<|>香草扁桃酸 is a metabolic byproduct of dopamine pathways<|>8)  \n##\n(\"relationship\"<|>儿茶酚胺<|>甲氧基肾上腺素<|>甲氧基肾上腺素 is a derivative of catecholamine metabolism<|>7)  \n##\n(\"relationship\"<|>儿茶酚胺<|>甲氧基去甲肾上腺素<|>甲氧基去甲肾上腺素 is a catecholamine metabolite<|>7)  \n##\n(\"relationship\"<|>α受体阻滞剂<|>β受体阻滞剂<|>β-blockers are added to α-blockers for PPGL preoperative preparation when tachycardia occurs<|>6)  \n##\n(\"relationship\"<|>PPGL<|>儿茶酚胺<|>PPGL diagnosis and monitoring requires catecholamine testing<|>9)  \n##\n(\"relationship\"<|>PPGL<|>多巴胺<|>Dopamine and its metabolites are measured in PPGL biochemical evaluation<|>8)  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558818, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 576, "prompt_tokens": 3120, "total_tokens": 3696, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 3072}, "prompt_cache_hit_tokens": 3072, "prompt_cache_miss_tokens": 48}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 多巴胺和终末代谢产物高香草酸和香草扁桃酸浓\n度[724,727] 。\n　　　根据患者病情选择个体化定位检查 :推荐 CT为  肿瘤定位的首选影像学检查[724,728-729] ;MRI用于颅底  和颈部 PGL、体内无存留金属异物、对 CT显影剂过  敏、儿童、孕妇等需减少放射性暴露的人群 ;必要时进  行正 电 子 发 射 体 层 成 像 (positron emission tomo- graphy,PET)-CT[730] 。有转移或不能手术的 PPGL 患 者 先 做 131碘-间 碘 苄 胍 (131I-metaiodobenzylguani- dine,131I-MIBG) 核 素 显 像 以 评 价 其 治 疗 的 可 能  性[731] 。其他影像学检查需咨询相关专业科室。\n　　　推荐所有 PPGL患者均应到正规实验室根据肿 瘤定位、性质和儿茶酚胺生化表型、家族史等选择相应 致病基因检测。\n　10.6.5  治疗   PPGL是涉及到多学科的内分泌复杂  疑难性疾病 ,应组建多学科团队进行分阶段协同诊治。 除 HNPGL和分泌多巴胺的肿瘤外 ,其余患者均应先  服用 α受体阻滞剂做术前准备 2~4周 ,心动过速时可  加用 β受体阻滞剂 ;对大多数 PCC行腹腔镜微创手  术 ;对大多数 PGL、肿瘤直径>6 cm、侵袭性 PPGL行  开放式手术 ;对双侧 PCC应采取保留部分皮质的肾上  腺切除术[732] 。\n　　　术前准备充分的标准 : ①持续性高血压患者血 压≤140/90mmHg,阵发性高血压发作频率减少、幅 度降低 ;②血容量恢复 ,无明显体位性低血压 ; ③高代 谢症群及糖代谢异常改善 ; ④术前药物准备时间有个 体差异 ,一般 2~4周 ,伴严重并发症的患者术前准备 时间相应延长并应由相关多学科会诊。\n　10.6.6   预后及随访    PPGL患者应进行个体化管 理 ,术后 24~48h密切监测血压和心率 ;通常应终身 随访 ,每年至少复查 1次 ;儿童、青少年、有 PPGL家族 史和基因突变、转移性 PPGL 患者 应 3~ 6 月 随 访 1次 ,定期检测儿茶酚胺、甲氧基肾上腺素及甲氧基去 甲肾上腺素及影像学检查 ,其直系亲属应检测基因并 定期进行检查。\n10.7   其他内分泌性高血压\n　10.7.1  库欣综合征    库欣综合征又称皮质醇增多 症 ,系肾上腺皮质分泌过多糖皮质激素导致的以向心 性肥胖、满月脸、多血质外貌、紫纹、高血压、高血糖和 骨质 疏 松 为 表 现 的 临 床 综 合 征 。 病 因 包 括 垂 体\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>PPGL<|>ORGANIZATION<|>PPGL is a complex endocrine disease involving multidisciplinary teams for diagnosis and treatment, including preoperative preparation and surgical options\")\n##\n(\"entity\"<|>HNPGL<|>ORGANIZATION<|>HNPGL is a type of tumor that does not require preoperative α-receptor blockers, unlike most PPGL cases\")\n##\n(\"entity\"<|>PCC<|>ORGANIZATION<|>PCC (Pheochromocytoma) is a tumor that typically requires laparoscopic minimally invasive surgery\")\n##\n(\"entity\"<|>PGL<|>ORGANIZATION<|>PGL (Paraganglioma) often requires open surgery, especially for tumors larger than 6 cm or invasive types\")\n##\n(\"entity\"<|>CT<|>ORGANIZATION<|>CT is the preferred imaging method for tumor localization in PPGL patients\")\n##\n(\"entity\"<|>MRI<|>ORGANIZATION<|>MRI is used for PPGL patients with specific conditions like metal implants, contrast allergies, or needing reduced radiation exposure\")\n##\n(\"entity\"<|>PET-CT<|>ORGANIZATION<|>PET-CT is an advanced imaging technique used for PPGL patients when necessary\")\n##\n(\"entity\"<|>131I-MIBG<|>ORGANIZATION<|>131I-MIBG is a nuclear imaging agent used to evaluate treatment possibilities for metastatic or inoperable PPGL\")\n##\n(\"entity\"<|>库欣综合征<|>EVENT<|>库欣综合征 is a clinical syndrome caused by excessive cortisol secretion, leading to symptoms like central obesity, hypertension, and osteoporosis\")\n##\n(\"relationship\"<|>PPGL<|>HNPGL<|>PPGL and HNPGL are both types of endocrine tumors, but HNPGL does not require the same preoperative preparation as PPGL<|>6)\n##\n(\"relationship\"<|>PPGL<|>PCC<|>PCC is a type of PPGL that typically requires laparoscopic surgery<|>7)\n##\n(\"relationship\"<|>PPGL<|>PGL<|>PGL is a type of PPGL that often requires open surgery<|>7)\n##\n(\"relationship\"<|>CT<|>MRI<|>CT and MRI are both imaging methods used for PPGL, with MRI preferred in specific cases<|>5)\n##\n(\"relationship\"<|>PET-CT<|>131I-MIBG<|>PET-CT and 131I-MIBG are both imaging techniques used for PPGL, with 131I-MIBG specifically for metastatic or inoperable cases<|>5)\n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_471baf3343ca2cb053f98e285b6d98387c4855ed742876ab7de930dcd3f66f76_v2"}